Albert Bourla (Greek: Άλμπερτ Μπουρλά; born October 21, 1961) is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions.

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, “Breakthroughs that change patients’ lives,” with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

Dec 30, 2021 · Albert Bourla is a Greek-American health executive. He began his professional career working as a veterinarian in Greece before joining Pfizer in 1993. He served in multiple senior global positions for over 25 years and became the CEO of Pfizer in 2019.

1 day ago · Pfizer (PFE) CEO Albert Bourla told investors Tuesday morning that he is “cautiously optimistic” about working with Robert F. Kennedy Jr., the expected next head of the U.S. Department of ...

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

Nov 9, 2021 · Albert Bourla became CEO of Pfizer in 2019 – the pinnacle of a career at Pfizer spanning more than two decades, multiple continents and several different business functions. When he took the helm of the global pharmaceutical company, he accelerated a transformation to become a more science-driven, innovative company.

Albert Bourla, CEO of Pfizer since 2019, led the company through a global pandemic and rapidly developed and deployed a vaccine that was eventually taken by millions. That move alone nearly...

May 2, 2024 · In 2022, Bourla doubled down on his original mission, launching the Accord for a Healthier World, in which Pfizer committed to provide 23 medicines, including vaccines,...

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.